Cross Country Healthcare, Inc. (CCRN) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CCRN Revenue Growth
Revenue Breakdown (FY 2024)
CCRN's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
CCRN Revenue Analysis (2014–2025)
As of May 6, 2026, Cross Country Healthcare, Inc. (CCRN) generated trailing twelve-month (TTM) revenue of $1.05 billion, reflecting significant decline in growth of -23.6% year-over-year. The most recent quarter (Q4 2025) recorded $236.8 million in revenue, down 5.3% sequentially.
Looking at the longer-term picture, CCRN's 5-year compound annual growth rate (CAGR) stands at +4.7%, indicating moderate growth over time. The company achieved its highest annual revenue of $2.80 billion in 2022.
Revenue diversification analysis shows CCRN's business is primarily driven by Other Services (100%). With over half of revenue concentrated in Other Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including AMN (-8.5% YoY), TBI (-18.8% YoY), and HCSG (+7.1% YoY), CCRN has underperformed the peer group in terms of revenue growth. Compare CCRN vs AMN →
CCRN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CCRNCurrent | $1.1B | -23.6% | +4.7% | -0.3% | |
 AMN | $2.7B | -8.5% | +2.7% | 1.2% | |
 TBI | $1.6B | -18.8% | -2.6% | -1.7% | |
 HCSG | $1.8B | +7.1% | +0.9% | 2.6% | |
 KELYA | $4.3B | -1.9% | -1.2% | -1.6% | |
 MAN | $18.0B | +0.6% | -0.0% | 1.3% |
CCRN Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.05B | -21.6% | $196.8M | 18.7% | $-3,462,000 | -0.3% |
| 2024 | $1.34B | -33.5% | $274.3M | 20.4% | $-16,865,000 | -1.3% |
| 2023 | $2.02B | -28.0% | $450.4M | 22.3% | $112.7M | 5.6% |
| 2022 | $2.80B | +67.2% | $624.5M | 22.3% | $269.9M | 9.6% |
| 2021 | $1.68B | +100.5% | $375.0M | 22.4% | $139.3M | 8.3% |
| 2020 | $836.4M | +1.7% | $202.7M | 24.2% | $-9,160,000 | -1.1% |
| 2019 | $822.2M | +0.7% | $204.0M | 24.8% | $-15,711,000 | -1.9% |
| 2018 | $816.5M | -5.6% | $209.6M | 25.7% | $-12,880,000 | -1.6% |
| 2017 | $865.0M | +3.8% | $228.6M | 26.4% | $11.7M | 1.4% |
| 2016 | $833.5M | +8.6% | $221.7M | 26.6% | $6.2M | 0.7% |
See CCRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCRN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CCRN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCCRN — Frequently Asked Questions
Quick answers to the most common questions about buying CCRN stock.
Is CCRN's revenue growth accelerating or slowing?
CCRN revenue declined -23.6% year-over-year, contrasting with the 5-year CAGR of +4.7%. TTM revenue fell to $1.1B. This reverses the prior growth trend.
What is CCRN's long-term revenue growth rate?
Cross Country Healthcare, Inc.'s 5-year revenue CAGR of +4.7% reflects the variable expansion pattern. Current YoY growth of -23.6% is below this long-term average.
How is CCRN's revenue distributed by segment?
CCRN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.